News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

XTend Medical (XMDC.PK) Gears Up for BioHarp Production



8/25/2010 10:48:33 AM

SUN VALLEY, CA--(Marketwire - August 25, 2010) -

XTend Medical Corporation (PINKSHEETS: XMDC), a company that specializes in delivering life-changing medical technology to healthcare organizations globally, has begun lining up manufacturers and software developers to commercialize the BioHarp Medical Device.

Mr. Paul D. Lisenby, the CEO of XTend Medical Corporation, stated, "We are hopeful and confident that through the mediation process in Delaware on September 30, 2010, the dispute over the ownership of the BioHarp will be resolved, and XTend can begin the process of commercializing the BioHarp technology. In the meantime, the company is contacting the vendors and software developers that we had previously lined up so that we can immediately commence manufacturing after the mediation process is complete. Our goal is to make sales initially in the veterinary sector while preparing to submit the BioHarp to the FDA for clearance to market to the healthcare sector. Our business model will dictate the pace and penetration needed in order to fulfill our fiscal goals. We will also be working on listing the company on a higher exchange with full disclosure to the investing public."

About XTend Medical

XTend Medical Corporation is a company that specializes in the sale, manufacturing, and distribution of the latest in medical devices and telemedicine solutions for the healthcare industry. The company is dedicated to insuring that the products and services that it offers to healthcare organizations, third-world countries, and physician groups are at the forefront of medical technology. For further information, please contact the company at info@bioharpunius.com or visit its website at www.bioharpunius.com.

Forward-Looking Statements

This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions, and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words "plan," "expect," "believe," and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets.


CONTACT
XTend Medical Corporation
info@bioharpunius.com


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES